Skip to main content
Clinical Trials/CTRI/2018/03/012451
CTRI/2018/03/012451
Completed
Phase 1

Patch Test (Skin Irritation)

Dabur India Limited0 sites10 target enrollmentTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Dabur India Limited
Enrollment
10
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
October 31, 2006
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Availability of subject for the entire study period and willingness to adhere to protocol requirements as evidenced by the written
  • informed consent.
  • 2\. Normal findings in the physical and clinical examinations.
  • 3\. Clinical Laboratory values within 10% above or below the laboratoryâ??s stated normal range, unless the investigators along with physicians decide that they are not clinically significant and record this fact on the case report form.
  • 4\. A Non\-Smoker.
  • 5\. Asian males of Indian origin.

Exclusion Criteria

  • 1\. History of hypersensitivity to the study formulations or related
  • 2\. Significant history or presence of psychiatric, gastro intestinal, liver
  • or kidney disorder/impairments, or any other conditions known to
  • interfere with the absorption, distribution, metabolism or excretion of
  • common medications.
  • 3\. Significant history of asthma, chronic bronchitis or other
  • bronchospastic condition.
  • 4\. Significant history or presence of glaucoma, cardiovascular or
  • hematological disease.
  • 5\. Any clinically significant illness during the 4 weeks prior to day one

Outcomes

Primary Outcomes

Not specified

Similar Trials